Lu Meng
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study.
Journal: Journal of neuro-oncology
Published: October 30, 2025
Mechanisms Underlying Radioresistance and Reversal Strategies in Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: May 27, 2025
FOXO3a regulation of non-small cell lung cancer radiotherapy resistance through the PINK1/Parkin pathway of protective mitophagy.
Journal: Translational lung cancer research
Published: February 23, 2025
Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 21, 2024
G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases.
Journal: International immunopharmacology
Published: December 05, 2023
A retrospective comparative cohort study: concurrent versus consolidative immunotherapy with chemoradiotherapy in EGFR- or ALK-negative unresectable stage III non-small cell lung cancer.
Journal: Translational lung cancer research
Published: September 04, 2023
PD-L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real-world evidence.
Journal: Cancer medicine
Published: August 01, 2023
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer.
Journal: Cancer biology & therapy
Published: May 03, 2023
Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma.
Journal: Cancer research
Published: October 05, 2022
The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients.
Journal: Frontiers in immunology
Published: June 11, 2021
Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression.
Journal: Frontiers in oncology
Published: August 16, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026